Fluid Management Therapy Suite
PIVOTAL CHOICES IN FLUID THERAPY
More than 80% of hospitalised patients receive intravenous (IV) fluids.1 Thus, judicious fluid management is a priority throughout the care continuum for individual clinicians and health systems. Empowering clinicians to deliver the right fluids at the right time means making a pivotal choice: the right healthcare partner. Baxter offers a range of fluid management products that may help providers improve outcomes by making evidence-based, personalised fluid decisions.
OPTIMAL FLUID CHOICES: EVIDENCE-BASED AND INDIVIDUALISED
Fluid therapy choices can influence outcomes. Studies show that giving too little or too much fluid can lead to serious complications and contribute to rising healthcare costs.2,3 On the other hand, proper fluid management may improve clinical outcomes, potentially saving millions in operating costs, by reducing the initiation of mechanical ventilation and acute dialysis, as well as length of stay.4-7
Each patient has individualised, fluctuating fluid needs. Studies show that only about 50% of haemodynamically unstable patients will respond to IV fluids with increased cardiac output and perfusion.8 Therefore, assessing whether fluid will be of benefit to a patient is a critical step in helping to optimise treatment. Clinicians need real-time, precise physiologic data to make well-informed choices about whether fluid is the right intervention and, if so, what type of fluid and how much is appropriate to support the patient's pathway to recovery.
A TRUSTED PARTNER
Baxter brings together key products needed to support improved fluid management: the non-invasive Starling Fluid Management Monitoring System to provide central flow measurement and accurate, individualised fluid insights anywhere in the hospital4,9; a comprehensive portfolio of IV solutions; and the Equilibria Fluid Optimisation Program to offer clinicians tools, resources and training for making appropriate fluid choices and adopting sound fluid management practices. Baxter is the right partner to support you in strengthening your health system’s overall fluid management performance.
EXPLORE OUR FLUID MANAGEMENT THERAPY SUITE:
SV STARLING Monitor — Non-invasive haemodynamic monitoring system.
Intended purpose: The Starling SV system, with NIBP and SpO2 functionality, is intended for professional use in healthcare facilities. It is a portable non-invasive haemodynamic cardiac output monitor. It monitors and displays a patient's cardiac output (CO) in l/min with a non-invasive blood pressure (NIBP) function that non-invasively measures and displays blood pressure (diastolic, systolic and mean) and heart rate, and an SpO2 function that non-invasively measures and displays blood oxygen saturation (SpO2). The device displays the corresponding haemodynamic parameters based on measurements or measurement calculations already incorporated in the Starling SV.
Class IIa device. Notified body: MEDCERT - Germany (CE 0482).
Please refer to the instructions for use for information necessary for proper use.
Carefully read the instructions in the package insert.
Date of revision: 31 March 2020.
Baxter, Equilibria and Starling are trademarks of Baxter International Inc. or its subsidiaries.